Posts Tagged ‘DSCI’

DSCI ascends, MSFT steady, TZOO mauled

Thursday, February 3rd, 2011

Derma Sciences Inc. (Nasdaq: DSCI) shares traveled 39.3 percent Thursday to $9.29 Thursday, on volumes of 494,316, compared to its full-day average of around 27,000, after learning its diabetic foot-wound drug met their mid-stage trial goal.

Microsoft Corporation (Nasdaq: MSFT) bought and sold 34.3 million Thursday, trailing its all-day average of 59.4 million. Share prices dipped back 1.1 percent to $27.63, after announcing MSFT may use a sale of debt products to reward shareholders.

Travelzoo Inc. (Nasdaq: TZOO) fell in price 15.6 percent to $44.52 Thursday. Volume was 1.3 million compared to a daily average of 281,000, after announcing quarterly EPS of 23 cents, compared to nine cents in the prior-year quarter.

DSCI takes off, SIRI beams up, USAT loses grip

Monday, January 24th, 2011

Derma Sciences Inc. (Nasdaq: DSCI) shares mushroomed 25.63 percent to close Monday at $6.63. Volume for the stock was 308,259 shares, leaving in the dust a full-day average of 8,308. Princeton-based DSCI is a medical device and pharmaceutical company focused on advanced wound care.

Sirius XM Radio Inc. (Nasdaq: SIRI) dealt in 50.8 million shares Monday, just a hair below its full-day average. Share prices were up 1.9 percent to $1.58, after expressing desire to raise its basic monthly subscription price from $12.95.

USA Technologies, Inc. (Nasdaq: USAT) dunked 7.8 percent to $1.53 Monday. Volume for the stock was 874,814 shares, doubling its daily average. Malvern, Pa.-based USAT is a leader in the networking of wireless cashless transactions.